Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
Experimental Treatment Induces Remission in Multiple Sclerosis
February 16th 2017A new treatment option using stem cell transplants was shown to induce sustained remission of relapsing-remitting multiple sclerosis (MS). More than two-thirds of participants had no signs of progression of disability, relapse of MS symptoms, or new brain lesions after 5 years.
Proposed Rule Shortens ACA Open Enrollment Period
February 15th 2017As Republicans debate how to move forward with repealing and replacing or reforming the Affordable Care Act, the Trump administration released a proposed rule to help stabilize the market in 2018. The rule includes a shorter open enrollment period.
Tom Price Is Confirmed as HHS Secretary, Will Lead ACA Repeal
February 10th 2017Early in the morning on Friday, the Senate voted along party lines (52-47) to confirm US Rep. Tom Price, R-Georgia, as secretary of HHS. President Donald Trump nominated Price with the expectation that he will lead the charge to repeal and replace the Affordable Care Act.
5 Things to Know About Block Grants in Medicaid
February 10th 2017Now that the Senate has confirmed US Rep. Tom Price, R-Georgia, as HHS secretary, Republicans will start to look toward making changes to the Affordable Care Act and Medicaid. Here is a look at block grants, which the GOP is considering using to reform the Medicaid program.
Anthem-Cigna Merger Blocked; Judge Cites Anticompetitive Effects
February 9th 2017A judge has blocked the proposed merger of Anthem and Cigna, saying consolidation would likely result in higher prices and have other anticompetitive effects. The ruling comes just 2 weeks after another judge blocked the Aetna-Humana merger.
Implementing Alternative Payment Models: Just Do It, Advocate Panelists at AcademyHealth
February 7th 2017Payment reform in the United States has been going on for years, and a panel at the AcademyHealth National Health Policy Conference analyzed how much progress has been made to move away from fee-for-service, and what the evidence on alternative payment models has found.
FOURIER Study Finds Repatha Reduces Risk of Cardiovascular Events
February 4th 2017Amgen's Repatha was shown to reduce the risk of cardiovascular events, such as cardiovascular death and myocardial infarction, in phase 3 of the FOURIER study. Full results will be presented in March 2017 at the American College of Cardiology 66th Scientific Sessions.
Analysis Finds Alemtuzumab Most Cost-Effective Treatment for Multiple Sclerosis
February 2nd 2017A review of 15 disease-modifying therapies (DMTs) for the treatment of relapsing-remitting and primary-progressive multiple sclerosis (MS) has found that prices for most of these drugs are not well-aligned with added value for patients.
Medicare's VBP Has Led to Little Meaningful Gains in Patient Experience
January 28th 2017CMS has tried to improve patient experience by tying payments to performance as part of the Value-Based Purchasing (VBP) program; however, a paper published in Health Affairs found no evidence that the program has had a beneficial effect.
Rand Paul's ACA Replacement Relies on HSAs and Selling Across State Lines
January 26th 2017Senator Rand Paul, R-Kentucky, provides his plan to replace the Affordable Care Act, which includes expanding the use of health savings accounts and allowing health insurance to be sold and purchased across state lines.
Cassidy, Collins Unveil Details to ACA Replacement Proposal
January 24th 2017A new healthcare reform legislation was introduced Monday by Bill Cassidy, MD, R-Louisiana, and Susan Collins, R-Maine. The proposed Patient Freedom Act would not fully repeal the Affordable Care Act (ACA), but instead, would place more power in the hands of the states by giving them the option of staying with the ACA or choosing another option.
Missed Opportunity to Test Patients With Severe Mental Illness for HIV
January 21st 2017Despite being up to 15 times more likely to be HIV positive, people with bipolar disorder, schizophrenia, and major depression with psychosis aren’t much more likely than the general population to be tested for the virus.
Nearly Half of New Drugs Approved in 2016 Were Orphan Drugs
January 17th 2017Among the 9 new orphan drugs approved by the FDA in 2016 were 3 treatments for rare diseases that, so far, had no approved treatments: Duchenne muscular dystrophy, spinal muscular atrophy, and severe hepatic veno-occlusive disease.
A Better Way to Cover High-Value Services
January 9th 2017Rising healthcare expenditures, leading to increased consumer cost sharing, is a top concern in healthcare that crosses party lines. In a new commentary in JAMA Internal Medicine, A. Mark Fendrick, MD, and Michael E. Chernew, PhD, co-editors-in-chief of The American Journal of Managed Care, highlighted the need for a “smarter” deductible.
5 Key Takeaways From CMS' Andy Slavitt
January 6th 2017As the team at CMS prepares to hand the reins over to the next administration, Andy Slavitt, acting administrator of CMS, took the time to speak with Mandi Bishop, MA, CEO of Aloha Health, in the latest podcast of Managed Care Cast about what he learned in his role and what the next administration should keep in mind.